Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
19.22
-0.64 (-3.22%)
At close: Mar 5, 2026, 4:00 PM EST
19.22
0.00 (0.00%)
After-hours: Mar 5, 2026, 4:01 PM EST
Caris Life Sciences Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Caris Life Sciences stock have an average target of 33.67, with a low estimate of 28 and a high estimate of 42. The average target predicts an increase of 75.18% from the current stock price of 19.22.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Caris Life Sciences stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 7 | 7 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $38 → $34 | Buy | Maintains | $38 → $34 | +76.90% | Feb 27, 2026 |
| Baird | Baird | Buy Maintains $26 → $28 | Buy | Maintains | $26 → $28 | +45.68% | Feb 27, 2026 |
| BTIG | BTIG | Strong Buy Maintains $45 → $38 | Strong Buy | Maintains | $45 → $38 | +97.71% | Feb 27, 2026 |
| Baird | Baird | Buy Initiates $26 | Buy | Initiates | $26 | +35.28% | Feb 17, 2026 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $28 → $30 | Hold | Maintains | $28 → $30 | +56.09% | Dec 22, 2025 |
Financial Forecast
Revenue This Year
1.01B
from 812.03M
Increased by 24.26%
Revenue Next Year
1.24B
from 1.01B
Increased by 22.60%
EPS This Year
0.19
from -3.22
EPS Next Year
0.39
from 0.19
Increased by 100.91%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 1.1B | 1.4B | |||
| Avg | 1.0B | 1.2B | |||
| Low | 945.7M | 1.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 30.9% | 34.3% | |||
| Avg | 24.3% | 22.6% | |||
| Low | 16.5% | 14.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 0.48 | 0.56 | |||
| Avg | 0.19 | 0.39 | |||
| Low | 0.05 | 0.14 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 188.8% | |||
| Avg | - | 100.9% | |||
| Low | - | -28.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.